Agios Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US00847X1046

SecurityAGIO / Agios Pharmaceuticals, Inc.
InstitutionAmalgamated Bank
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Amalgamated Bank closes position in AGIO / Agios Pharmaceuticals, Inc.

On May 8, 2026 - Amalgamated Bank filed a 13F-HR form disclosing ownership of 0 shares of Agios Pharmaceuticals, Inc. (US:AGIO) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 1,774 shares of Agios Pharmaceuticals, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -100.00 0
2026-02-05 2025-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 1,774 -183 -9.35 0 0.0003
2025-10-29 2025-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 1,957 0 0.00 0 0.0006
2025-08-04 2025-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 1,957 0 0.00 0 0.0005
2025-04-25 2025-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 1,957 7 0.36 0 0.0005
2025-02-04 2024-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 1,950 0 0.00 0 0.0005
2024-10-30 2024-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 1,950 0 0.00 0 0.0007
2024-08-12 2024-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 1,950 83 4.45 0 0.0007
2024-04-23 2024-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 1,867 -2,972 -61.42 0 0.0005
2024-02-06 2023-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 4,839 -556 -10.31 0 0.0009
2023-11-08 2023-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 5,395 0 0.00 0 0.0011
2023-08-11 2023-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 5,395 -374 -6.48 0 0.0012
2023-05-02 2023-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 5,769 -1,291 -18.29 0 0.0011
2023-02-10 2022-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 7,060 97 1.39 0 -100.00 0.0018
2022-11-09 2022-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 6,963 68 0.99 197 28.76 0.0019
2022-08-15 2022-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 6,895 339 5.17 153 -19.90 0.0014
2022-08-25 2022-03-31 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 6,556 -738 -10.12 191 -20.42 0.0015
2022-06-30 2022-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 6,556 -738 191 0.0015
2022-02-15 2021-12-31 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 7,294 -424 -5.49 240 -32.58 0.0018
2022-02-15 2021-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 7,294 -424 240 0.0018
2021-10-29 2021-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 7,718 -934 -10.80 356 -25.37 0.0030
2021-08-16 2021-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 8,652 1,107 14.67 477 22.31 0.0038
2021-05-13 2021-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 7,545 -558 -6.89 390 11.11 0.0146
2021-02-12 2020-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 8,103 -4 -0.05 351 23.59 0.0133
2020-10-30 2020-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 8,107 -13 -0.16 284 -34.56 0.0123
2020-08-10 2020-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 8,120 -5,147 -38.80 434 -7.86 0.0201
2020-05-13 2020-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 13,267 -179 -1.33 471 -26.64 0.0115
2020-02-13 2019-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 13,446 2,861 27.03 642 87.17 0.0118
2019-11-13 2019-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 10,585 113 1.08 343 -34.29 0.0072
2019-08-14 2019-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 10,472 -942 -8.25 522 -32.21 0.0122
2019-05-15 2019-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 11,414 185 1.65 770 48.65 0.0187
2019-02-15 2018-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 11,229 4,112 57.78 518 -5.65 0.0147
2018-11-14 2018-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 7,117 -4,550 -39.00 549 -44.15 0.0136
2018-07-18 2018-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 11,667 1,194 11.40 983 14.84 0.0240
2018-05-22 2018-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 10,473 2,186 26.38 856 80.59 0.0227
2018-02-13 2017-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 8,287 460 5.88 474 -9.20 0.0128
2017-11-09 2017-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 7,827 897 12.94 522 46.22 0.0163
2017-08-10 2017-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 6,930 2,407 53.22 357 35.23 0.0117
2017-05-12 2017-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 4,523 -1,002 -18.14 264 14.29 0.0131
2017-02-14 2016-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 5,525 772 16.24 231 -7.97 0.0104
2016-11-15 2016-09-30 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 4,753 4,753 0.00 251 0.0146
2016-02-10 2015-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -3,021 -100.00 0 -100.00
2015-11-04 2015-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 3,021 44 1.48 213 -35.65 0.0223
2015-07-10 2015-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 2,977 2,977 331 0.0325
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.